| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Aug 14, 2023 | ELI LILLY & Co | 10% Owner | Buy | 100.0 | +100 | 100.00% | ✗ | $25.6M |
| Nov 30, 2022 | Dec 1, 2022 | ELI LILLY & Co | 10% Owner | Buy | 100.0 | +100 | 100.00% | ✗ | $374.9M |
| Jan 22, 2021 | Jan 22, 2021 | ELI LILLY & Co | 10% Owner | Buy | 100.0 | +100 | 100.00% | ✗ | $771.4M |
| Dec 8, 2020 | Dec 10, 2020 | ELI LILLY & Co | 10% Owner | Buy | 100.0 | +300,000 | 12.27% | ✗ | $5.4M |
| Apr 12, 2016 | Apr 14, 2016 | Spyre Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +500,000 | 24.17% | ✗ | $5M |
| Nov 12, 2014 | Nov 12, 2014 | Coherus Oncology, Inc. | Other | Buy | 95.0 | +164,963 | 5.73% | ✗ | $2.2M |
| Apr 15, 2014 | Apr 15, 2014 | Dare Bioscience, Inc. | 10% Owner | Buy | 100.0 | +733,445 | 45.20% | ✗ | $5.1M |